Latest News in the pharma Industry

Research & Development

Maverick: an emergency auto-injector designed for total patient safety

Maverick: an emergency auto-injector designed for total patient safety

16 Sep 2020

The Maverick emergency auto-injector merges Duoject Medical System’s design and development expertise with Stevanato Group’s contract manufacturing capabilities. Six Human Factor studies conducted over 150 patients show how the current conf...

Read more 
Humanigen and Lonza collaborate to expand manufacturing of COVID-19 therapeutic candidate

Humanigen and Lonza collaborate to expand manufacturing of COVID-19 therapeutic candidate

15 Sep 2020

Humanigen's proprietary monoclonal antibody may prevent and treat cytokine storm, which is believed to trigger the acute respiratory distress syndrome in severe cases of COVID-19.

Read more 
Evotec and Bioaster partner to build technology and innovation hub in Lyon

Evotec and Bioaster partner to build technology and innovation hub in Lyon

14 Sep 2020

Together, the companies will aim to put forward new research projects against infectious diseases and antimicrobial resistance, potentially creating new therapies and technologies.

Read more 
Exelixis and Catalent collaborate to develop antibody-drug conjugates

Exelixis and Catalent collaborate to develop antibody-drug conjugates

8 Sep 2020

The partnership will focus on developing multiple ADCs using Catalent’s proprietary SMARTag site-specific bioconjugation technology.

Read more 
Key trends boosting the post-pandemic CRO market

Key trends boosting the post-pandemic CRO market

8 Sep 2020

Hybrid clinical trials leveraging safety-focused, direct-to-consumer logistical solutions are taking center stage, ensuring research continuity.

Read more 
INOVIO signs up Thermo Fisher to support COVID-19 vaccine production

INOVIO signs up Thermo Fisher to support COVID-19 vaccine production

8 Sep 2020

The CDMO will support INOVIO's plans to have 100 million doses of COVID-19 vaccine candidate INO-4800 manufactured in 2021.

Read more 
AstraZeneca's COVID-19 vaccine candidate enters Phase III trials in the US

AstraZeneca's COVID-19 vaccine candidate enters Phase III trials in the US

2 Sep 2020

Trial enrolling up to 30,000 adults aged 18 years or over to assess safety, efficacy and immunogenicity of AZD1222 for the prevention of COVID-19.

Read more 
New syringe technology could make the 'uninjectable' injectable

New syringe technology could make the 'uninjectable' injectable

25 Aug 2020

Researchers have designed a simple, low-cost device for subcutaneous injection of viscous formulations.

Read more 
BMS adds lead TGF-beta asset to portfolio through acquisition

BMS adds lead TGF-beta asset to portfolio through acquisition

25 Aug 2020

Forbius's lead investigational asset, AVID200 holds promise as an effective and well-tolerated therapeutic in fibrotic diseases and immuno-oncology.

Read more 
Catalent expands manufacturing support for COVID-19 vaccine AZD1222

Catalent expands manufacturing support for COVID-19 vaccine AZD1222

24 Aug 2020

The company will prepare the Harmans facility to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing later this year.

Read more 
CRO Europital opens new UK site in response to urgent demand

CRO Europital opens new UK site in response to urgent demand

24 Aug 2020

The company will target working with small and medium biotechs who require a science-driven, rather than a volume-driven partner.

Read more 
J&J agrees in principle to supply UK with its COVID-19 vaccine candidate

J&J agrees in principle to supply UK with its COVID-19 vaccine candidate

18 Aug 2020

Company working to ensure broad global access to COVID-19 vaccine candidate, following approval from regulators.

Read more